Skip to main content
. 2020 May 8;18(2):1559325820923825. doi: 10.1177/1559325820923825

Figure 3.

Figure 3.

Verification of splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. A, Verification of ANKRD52 splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. B, Verification of MFSD6 splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. C, Verification of NDE splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. D, Verification of GPR34 splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. E, Verification of PRKCSH splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. F, Verification of MAPK1IP1L splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. G, Verification of NUP210 splice variants by qRT-PCR in blood samples from patients with silicosis and normal control population. H, Determination of PRKCSH splice variants by qRT-PCR in A 459 cells with or without treatment with silica. I, Summary information of 2 PRKCSH splice variants, PRKCSH-1(ENST0000058750.5) and PRKCSH-2 (ENST00000593053.1), available on website of http://libdb.csu.edu.cn/rwt/PUBMED/http/MF3XTZJPMWYHG3LNMJXC655TMH/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000130175;r=19:11435635-11450968;t=ENST00000592741.